CereVasc, Inc. is a clinical-stage medical device company developing novel, minimally invasive treatments for patients with neurological diseases. Its lead product, the eShunt System, uses percutaneous transvenous-transdural access to the central nervous system to treat communicating hydrocephalus — including normal pressure hydrocephalus (NPH) — as a less invasive alternative to conventional neurosurgical shunt placement. The eShunt System is an investigational device limited by United States federal law to investigational use, and is being evaluated in the STRIDE pivotal study (NCT06498960). CereVasc raised a $70M Series B in 2024 and has received FDA Breakthrough Device Designation. The company builds implantable hardware and publishes no public API, developer program, or machine-readable specification.
CereVasc is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Neurology, and Hydrocephalus.
CereVasc’s developer surface includes engineering blog and 7 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/cerevasc: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: cerevasc
name: CereVasc
description: CereVasc, Inc. is a clinical-stage medical device company developing novel, minimally invasive treatments for
patients with neurological diseases. Its lead product, the eShunt System, uses percutaneous transvenous-transdural access
to the central nervous system to treat communicating hydrocephalus — including normal pressure hydrocephalus (NPH) — as
a less invasive alternative to conventional neurosurgical shunt placement. The eShunt System is an investigational device
limited by United States federal law to investigational use, and is being evaluated in the STRIDE pivotal study (NCT06498960).
CereVasc raised a $70M Series B in 2024 and has received FDA Breakthrough Device Designation. The company builds implantable
hardware and publishes no public API, developer program, or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/cerevasc/refs/heads/main/apis.yml
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://cerevasc.com/wp-content/uploads/2023/10/CereVasc-logo-%C2%AEweb-main.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-09'
modified: '2026-08-09'
tags:
- Company
- Medical Devices
- Healthcare
- Neurology
- Hydrocephalus
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/cerevasc-domain-security.yml
- type: Website
url: https://cerevasc.com/
- type: About
url: https://cerevasc.com/eshunt-system-cerevasc/
- type: Contact
url: https://cerevasc.com/contact-cerevasc/
- type: Blog
url: https://cerevasc.com/press/
- type: BlogRSS
url: https://cerevasc.com/feed/
- type: PrivacyPolicy
url: https://cerevasc.com/privacy-policy/
- type: SecondaryMarketListing
url: https://forgeglobal.com/cerevasc_stock/
x-enrichment:
date: '2026-08-09'
status: minimal
artifacts_added: 1
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: CereVasc is a clinical-stage neurovascular implant maker whose product is the physical eShunt device; its WordPress
site has no /developers, /api or /docs path, no api./developer./docs. subdomain resolves in DNS, and every discovery probe
(/openapi.json, /llms.txt, /.well-known/agent-card.json) returned 404.
evidence:
- url: https://cerevasc.com/openapi.json
status: 404
- url: https://cerevasc.com/developers
status: 404
- url: https://cerevasc.com/llms.txt
status: 404
- url: https://cerevasc.com/.well-known/agent-card.json
status: 404
- url: https://cerevasc.com/.well-known/security.txt
status: 404
- url: https://cerevasc.com/
status: 200
checked: '2026-08-09'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.